NCT05981703 2026-03-04A Study Investigating BGB-26808 Alone or in Combination With Tislelizumab in Participants With Advanced Solid TumorsBeOne MedicinesPhase 1 Recruiting217 enrolled
NCT03874897 2024-04-30Chimeric Antigen Receptor T Cells Targeting claudin18.2 in Solid Tumors.Peking UniversityPhase 1 Completed134 enrolled